Max Sakajja
Corporate Officer/Principal chez HANSA BIOPHARMA AB
Provenance du réseau au premier degré de Max Sakajja
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 28 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Max Sakajja via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| University of Lund | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree Graduate Degree Undergraduate Degree | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Uppsala | College/University | Graduate Degree Corporate Officer/Principal Graduate Degree | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
X-Vax Technology, Inc.
 X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Nexttobe AB
 Nexttobe AB Investment ManagersFinance Nexttobe AB focuses on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies. It is a venture capital/private equity firm that invests in technology and consumer companies. The company was founded by Bengt Ågerup in 2011 and is headquartered in Uppsala, Sweden. | Investment Managers | Chairman Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| Copenhagen Business School | College/University | Undergraduate Degree Graduate Degree | |
| ACTIVE BIOTECH AB | Biotechnology | Director of Finance/CFO General Counsel | |
Avillion LLP
 Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The company is based in Amsterdam, Netherlands. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Microbiotica Ltd.
 Microbiotica Ltd. BiotechnologyHealth Technology Microbiotica Ltd. performs research and experimental development on biotechnology. The company was founded by Michael Anthony Romanos, Trevor David Lawley and Gordon Dougan in December 2016 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chairman | |
| University of California, Santa Barbara | College/University | Graduate Degree | |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Founder | |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
| PHARVARIS N.V. | Pharmaceuticals: Major | Founder | |
| Cartela R&D AB | Director/Board Member | ||
| BUFAB AB | Wholesale Distributors | Director/Board Member | |
Biolin Scientific AB
 Biolin Scientific AB Medical SpecialtiesHealth Technology Biolin Scientific AB develops, manufactures, markets, and sells analytical instruments and related products. Its parent company involves in the discovery of drugs, develops solutions for energy and materials, and performs research at the frontiers of science and technology. The firm's customers include companies working with pharmaceuticals, energy, chemicals, and advanced materials, as well as academic and governmental research institutes. The company was founded on September 19, 1984 and is headquartered in Vastra Frolunda, Sweden. | Medical Specialties | Chief Executive Officer | |
| VITROLIFE AB | Medical Specialties | Director of Finance/CFO | |
Volvo Trucks AB
 Volvo Trucks AB Trucks/Construction/Farm MachineryProducer Manufacturing Part of Volvo AB, Volvo Trucks AB supplies complete transport solutions for professional customers with its range of medium- and heavy-duty trucks. Volvo Trucks is based in Gothenburg, Sweden, and sells vehicles and services in more than 140 countries. The Swedish company has a network of dealers with 2,300 service points in about 130 countries and assembles its trucks in 12 countries worldwide. In 2022, approximately 145,000 Volvo trucks were delivered globally. Volvo Trucks is one of the world's leading manufacturers of trucks, buses, construction equipment, and marine and industrial engines, providing complete solutions for financing and service. The company's core values are quality, safety, and environmental care. It is the second-largest heavy-duty truck brand in the world, with over 95%% of the trucks built being over 16 tonnes. | Trucks/Construction/Farm Machinery | Sales & Marketing | |
| ADDLIFE AB | Medical/Nursing Services | Director/Board Member | |
Nilsagård Consulting AB
 Nilsagård Consulting AB Miscellaneous Commercial ServicesCommercial Services Nilsagård Consulting AB is a consulting private company based in Lidingö, Sweden. Nilsagård Consulting AB provides consulting services. The Swedish company was founded by Eva Nilsagård, who has been the CEO since incorporation. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Imatech Marin & Industri AB | Director/Board Member | ||
| Plastal Sverige AB | Director/Board Member | ||
| Plastal AS | Director/Board Member | ||
Plastal NV
 Plastal NV Auto Parts: OEMProducer Manufacturing Plastal NV is a Belgian company that specializes in manufacturing motor vehicle parts and accessories. The private company is based in Ghent, Belgium. | Auto Parts: OEM | Director/Board Member | |
INIM Pharma AB
 INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
InteRNA Technologies BV
 InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Chairman | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Chairman | |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ANOTO GROUP AB | Computer Peripherals | Director of Research - Fxd Inc | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director of Finance/CFO | |
Immedica Pharma AB
 Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman | |
| Instituto de Estudios Superiores de la Empresa | College/University | Masters Business Admin | |
Auris Medical AG
 Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Medical Specialties | Director/Board Member | |
| ALTAMIRA THERAPEUTICS LTD. | Biotechnology | Director/Board Member | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director of Finance/CFO | |
NorthSea Therapeutics BV
 NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | Biotechnology | Director of Finance/CFO |
Statistiques
Internationale
| Suède | 22 |
| Suisse | 10 |
| Etats-Unis | 7 |
| Pays-Bas | 5 |
| Danemark | 4 |
Sectorielle
| Health Technology | 35 |
| Consumer Services | 6 |
| Producer Manufacturing | 3 |
| Finance | 2 |
| Distribution Services | 2 |
Opérationnelle
| Director/Board Member | 92 |
| Corporate Officer/Principal | 58 |
| Chairman | 38 |
| Independent Dir/Board Member | 36 |
| Chief Executive Officer | 24 |
Relations les plus connectées
| Insiders | |
|---|---|
| Eva Nilsagård | 30 |
| Folke Per-Olof Wallström | 30 |
| Ulf Arne Wiinberg | 26 |
| Anders Gersel Pedersen | 24 |
| Johannes G. C. P. Schikan | 22 |
| Mats Blom | 15 |
| Achim Kaufhold | 14 |
| Peter Nicklin | 14 |
| Stina Margareta Gestrelius | 13 |
| Søren Tulstrup | 13 |
| Hitto Kaufmann | 9 |
| Hilary Malone | 7 |
| Angelica Loskog | 7 |
| Andreas Eggert | 6 |
| Göran Arvidson | 6 |
- Bourse
- Insiders
- Max Sakajja
- Connexions Sociétés
